Perform Another (Advanced) Search

1.  CenterWatch: Clinical Trials in Category (815) Renal Failure
...CenterWatch: Clinical Trials in Category (815) Renal Failure Renal Failure Country • [X]   China China Beijing : Research Site: A Study of Torasemide Compared With ...
View Page

2. Clinical Trial Results: Renal Failure
...Clinical Trial Results: Renal Failure Clinical Trial Results: Renal Failure Product Name: Torem [torasemide] Date of Report: 5/1/2006 ...
View Page

3.  Study Posting (4519) Trial #126403, Renal Failure, Shanghai, China
...Study Posting (4519) Trial #126403, Renal Failure, Shanghai, China Trial Information A Study of Torasemide Compared With Furosemide in Patients With Renal ...
View Page

4.  Study Posting (4519) Trial #126439, Renal Failure, Guangzhou, China
...Study Posting (4519) Trial #126439, Renal Failure, Guangzhou, China Trial Information A Study of Torasemide Compared With Furosemide in Patients With Renal ...
View Page

5.  Study Posting (4519) Trial #126402, Renal Failure, Beijing, China
...Study Posting (4519) Trial #126402, Renal Failure, Beijing, China Trial Information A Study of Torasemide Compared With Furosemide in Patients With Renal ...
View Page

6. Clinical Trial Results by Drug Names
...diuresis and safety of torasemide versus furosemide in the treatment of patients with acute/chronic renal failure or nephrotic syndrome. Fast Facts: Protocol number: ML18113 Sponsor: Shanghai Roche Pharmaceutical Ltd. Company division ...
View Page

7.  Study Posting (4519) Trial #103653, Anemia, Valence, France
...NADIR Study: A Study of Neorecormon (Epoetin Beta)in Anemic Patients With Diabetes and Chronic Renal Failure Who Are Not on Dialysis. Status: Completed Protocol Number: ML18730 Sponsor: Roche SAS Company Division ...
View Page

8.  Study Posting (4519) Trial #97502, Anemia, Toulouse, France
...NADIR Study: A Study of Neorecormon (Epoetin Beta)in Anemic Patients With Diabetes and Chronic Renal Failure Who Are Not on Dialysis. Status: Completed Protocol Number: ML18730 Sponsor: Roche SAS Company Division ...
View Page

9.  Study Posting (4519) Trial #104726, Anemia, Sens, France
...NADIR Study: A Study of Neorecormon (Epoetin Beta)in Anemic Patients With Diabetes and Chronic Renal Failure Who Are Not on Dialysis. Status: Completed Protocol Number: ML18730 Sponsor: Roche SAS Company Division ...
View Page

10.  Study Posting (4519) Trial #99312, Anemia, Reims, France
...NADIR Study: A Study of Neorecormon (Epoetin Beta)in Anemic Patients With Diabetes and Chronic Renal Failure Who Are Not on Dialysis. Status: Completed Protocol Number: ML18730 Sponsor: Roche SAS Company Division ...
View Page

11.  Study Posting (4519) Trial #102657, Anemia, Quimper, France
...NADIR Study: A Study of Neorecormon (Epoetin Beta)in Anemic Patients With Diabetes and Chronic Renal Failure Who Are Not on Dialysis. Status: Completed Protocol Number: ML18730 Sponsor: Roche SAS Company Division ...
View Page

12.  Study Posting (4519) Trial #97453, Anemia, Poitiers, France
...NADIR Study: A Study of Neorecormon (Epoetin Beta)in Anemic Patients With Diabetes and Chronic Renal Failure Who Are Not on Dialysis. Status: Completed Protocol Number: ML18730 Sponsor: Roche SAS Company Division ...
View Page

13.  Study Posting (4519) Trial #104715, Anemia, Poissy, France
...NADIR Study: A Study of Neorecormon (Epoetin Beta)in Anemic Patients With Diabetes and Chronic Renal Failure Who Are Not on Dialysis. Status: Completed Protocol Number: ML18730 Sponsor: Roche SAS Company Division ...
View Page

14.  Study Posting (4519) Trial #97435, Anemia, Paris, France
...NADIR Study: A Study of Neorecormon (Epoetin Beta)in Anemic Patients With Diabetes and Chronic Renal Failure Who Are Not on Dialysis. Status: Completed Protocol Number: ML18730 Sponsor: Roche SAS Company Division ...
View Page

15.  Study Posting (4519) Trial #100506, Anemia, Orleans, France
...NADIR Study: A Study of Neorecormon (Epoetin Beta)in Anemic Patients With Diabetes and Chronic Renal Failure Who Are Not on Dialysis. Status: Completed Protocol Number: ML18730 Sponsor: Roche SAS Company Division ...
View Page

16.  Study Posting (4519) Trial #103573, Anemia, Niort, France
...NADIR Study: A Study of Neorecormon (Epoetin Beta)in Anemic Patients With Diabetes and Chronic Renal Failure Who Are Not on Dialysis. Status: Completed Protocol Number: ML18730 Sponsor: Roche SAS Company Division ...
View Page

17.  Study Posting (4519) Trial #104730, Anemia, Maubeuge, France
...NADIR Study: A Study of Neorecormon (Epoetin Beta)in Anemic Patients With Diabetes and Chronic Renal Failure Who Are Not on Dialysis. Status: Completed Protocol Number: ML18730 Sponsor: Roche SAS Company Division ...
View Page

18.  Study Posting (4519) Trial #97308, Anemia, Lille, France
...NADIR Study: A Study of Neorecormon (Epoetin Beta)in Anemic Patients With Diabetes and Chronic Renal Failure Who Are Not on Dialysis. Status: Completed Protocol Number: ML18730 Sponsor: Roche SAS Company Division ...
View Page

19.  Study Posting (4519) Trial #104719, Anemia, Greize, France
...NADIR Study: A Study of Neorecormon (Epoetin Beta)in Anemic Patients With Diabetes and Chronic Renal Failure Who Are Not on Dialysis. Status: Completed Protocol Number: ML18730 Sponsor: Roche SAS Company Division ...
View Page

20.  Study Posting (4519) Trial #104725, Anemia, Evreux, France
...NADIR Study: A Study of Neorecormon (Epoetin Beta)in Anemic Patients With Diabetes and Chronic Renal Failure Who Are Not on Dialysis. Status: Completed Protocol Number: ML18730 Sponsor: Roche SAS Company Division ...
View Page